Its important to discuss any concerns with Dr
Reduced Reward-Driven Eating Emerging research suggests GLP-1 medications may also reduce the brains reward response to highly palatable foods essentially making junk food less appealing
Patients should contact their healthcare provider if they experience severe or persistent side effects, signs of hypoglycaemia (particularly if taking insulin or sulfonylureas), symptoms of pancreatitis (severe abdominal pain), or if there is no improvement in blood glucose control after 6 months of treatment at the maximum tolerated dose
The trial was sponsored by Novo Nordisk, the company that developed semaglutide
Your provider will demonstrate the technique and set your protocol at your consultation
GLP-1 diets have become one of the biggest topics in nutrition, largely because medications like Ozempic, Wegovy, and Mounjaro have transformed how people approach weight loss